Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Jeffrey A. Gilreath's publication output changed over time?
ScholarIQpublication output · 2010–2021
Output grew100% over the shown period — from 1 works in 2010 to 2 in 2021.
1
2
2
1
1
1
1
2
20102012201320152016201920202021
What are the most-cited papers on Jeffrey A. Gilreath?
ScholarIQmost cited works
Diagnosis and treatment of cancer‐related anemia
Jeffrey A. Gilreath, David D. Stenehjem, George M. Rodgers
American Journal of Hematology. 2013247 Citations
Cancer- and Chemotherapy-Induced Anemia
George M. Rodgers, Pamela S. Becker, Morey A. Blinder, David Cella, Asher Chanan‐Khan, Charles S. Cleeland, Peter F. Coccia, Benjamin Djulbegović, Jeffrey A. Gilreath, Eric H. Kraut, Ursula A. Matulonis, Michael Millenson, Denise K. Reinke, Joseph Rosenthal, Rowena Schwartz, Gerald A. Soff, Richard S. Stein, Gordana Vlahovic, Alva B. Weir
Journal of the National Comprehensive Cancer Network. 2012228 CitationsOPEN ACCESS
How I treat cancer-associated anemia
Jeffrey A. Gilreath, George M. Rodgers
Blood. 2020113 CitationsOPEN ACCESS
Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists
Jeffrey A. Gilreath, Mimi Lo, Joseph Bubalo
Drugs. 2021110 CitationsOPEN ACCESS
Studying Cancer-Related Fatigue: Report of the NCCN Scientific Research Committee
Joanne Mortimer, Andrea M. Barsevick, Charles L. Bennett, Ann M. Berger, Charles S. Cleeland, Shannon R. DeVader, Carmen P. Escalante, Jeffrey A. Gilreath, Arti Hurria, Tito R. Mendoza, Hope S. Rugo
Journal of the National Comprehensive Cancer Network. 201067 Citations
Related on ScholarIQ
University of Utah
Institution
Diagnosis and treatment of cancer‐related anemia
Paper
Cancer- and Chemotherapy-Induced Anemia
Paper
How I treat cancer-associated anemia
Paper
Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists
Paper
Studying Cancer-Related Fatigue: Report of the NCCN Scientific Research Committee
Paper